New study shows valbenazine may ease uncontrollable movements in mental health patients
NCT ID NCT05859698
First seen Jan 19, 2026 · Last updated Jun 16, 2026 · Updated 22 times
Summary
This study looked at how well valbenazine works for tardive dyskinesia, a condition causing uncontrollable movements often linked to psychiatric medications. 59 adults with schizophrenia, bipolar disorder, or depression took valbenazine for up to 24 weeks. Researchers measured changes in quality of life, daily functioning, and overall health to see if the drug helped reduce the impact of the movement disorder.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TARDIVE DYSKINESIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Neurocrine Clinical Site
Bryant, Arkansas, 72022, United States
-
Neurocrine Clinical Site
Anaheim, California, 92805, United States
-
Neurocrine Clinical Site
Orange, California, 92868, United States
-
Neurocrine Clinical Site
Torrance, California, 90504, United States
-
Neurocrine Clinical Site
Bonita Springs, Florida, 34134, United States
-
Neurocrine Clinical Site
Miami, Florida, 33176, United States
-
Neurocrine Clinical Site
Miami Lakes, Florida, 33016, United States
-
Neurocrine Clinical Site
Okeechobee, Florida, 34972, United States
-
Neurocrine Clinical Site
Tampa, Florida, 33629, United States
-
Neurocrine Clinical Site
Atlanta, Georgia, 30328, United States
-
Neurocrine Clinical Site
Augusta, Georgia, 30912, United States
-
Neurocrine Clinical Site
Marietta, Georgia, 30060, United States
-
Neurocrine Clinical Site
Lincoln, Nebraska, 68526, United States
-
Neurocrine Clinical Site
Beechwood, Ohio, 44122, United States
-
Neurocrine Clinical Site
Oklahoma City, Oklahoma, 73112, United States
-
Neurocrine Clinical Site
DeSoto, Texas, 75115, United States
-
Neurocrine Clinical Site
El Paso, Texas, 79902, United States
-
Neurocrine Clinical Site
Houston, Texas, 77030, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.